|
|
|
|
| 专题 |
最后回覆 |
昵称 |
内容 |
| 中国神威药业集团有限公司 |
2013-04-07T08:32 |
财经茄呢啡 |
神威药业（2877）主要从事研发及产销现代化中药，近年主打产品被列入基本药物目录，而且具充裕现金进行并购，加上注射液业务表现理想，去年下半年销情较上半年改善，预料按年能有双位数增长。 |
|
|
|
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window